Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 4
1988 6
1989 2
1990 9
1991 8
1992 12
1993 10
1994 7
1995 20
1996 12
1997 14
1998 15
1999 15
2000 20
2001 26
2002 22
2003 25
2004 27
2005 37
2006 40
2007 26
2008 33
2009 33
2010 31
2011 25
2012 33
2013 26
2014 21
2015 15
2016 10
2017 8
2018 4
2019 3
2020 2
2021 1
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

538 results

Results by year

Filters applied: . Clear all
Page 1
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women.
Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, Cuzick J, Jebb SA, Martin B, Cutler RG, Son TG, Maudsley S, Carlson OD, Egan JM, Flyvbjerg A, Howell A. Harvie MN, et al. Among authors: flyvbjerg a. Int J Obes (Lond). 2011 May;35(5):714-27. doi: 10.1038/ijo.2010.171. Epub 2010 Oct 5. Int J Obes (Lond). 2011. PMID: 20921964 Free PMC article. Clinical Trial.
Chromogranin A as a biomarker in cardiovascular disease.
Goetze JP, Alehagen U, Flyvbjerg A, Rehfeld JF. Goetze JP, et al. Among authors: flyvbjerg a. Biomark Med. 2014;8(1):133-40. doi: 10.2217/bmm.13.102. Biomark Med. 2014. PMID: 24325234 Review.
[Sleep impairment is a threat to good health].
Clark AJ, Jørgensen TS, Bonke J, Flyvbjerg A, Garde AH, Hermansen K, Krogholm K, Møller M, Sjödin A, Zachariae B, Jennum PJ. Clark AJ, et al. Among authors: flyvbjerg a. Ugeskr Laeger. 2016 May 9;178(19):V12150974. Ugeskr Laeger. 2016. PMID: 27188994 Free article. Review. Danish.
David versus Goliath.
Mollenhauer J, Stamou D, Flyvbjerg A, Wengel J, Gether U, Kjems J, Bjørnholm T, Besenbacher F. Mollenhauer J, et al. Among authors: flyvbjerg a. Nanomedicine. 2010 Aug;6(4):504-9. doi: 10.1016/j.nano.2010.04.002. Epub 2010 Apr 22. Nanomedicine. 2010. PMID: 20417315 No abstract available.
Making sense of chromogranin A in heart disease.
Goetze JP, Alehagen U, Flyvbjerg A, Rehfeld JF. Goetze JP, et al. Among authors: flyvbjerg a. Lancet Diabetes Endocrinol. 2013 Sep;1(1):7-8. doi: 10.1016/S2213-8587(13)70035-4. Epub 2013 Jun 13. Lancet Diabetes Endocrinol. 2013. PMID: 24622255 Review. No abstract available.
Insulin resistance: the cardiovascular aspect.
Dominguez H, Flyvbjerg A. Dominguez H, et al. Among authors: flyvbjerg a. Horm Metab Res. 2008 Sep;40(9):583-7. doi: 10.1055/s-0028-1082084. Epub 2008 Sep 15. Horm Metab Res. 2008. PMID: 18792868 No abstract available.
Diabetic kidney disease: the role of growth factors.
Flyvbjerg A, Grønbaek H, Bak M, Nielsen B, Christiansen T, Hill C, Logan A, Orskov H. Flyvbjerg A, et al. Nephrol Dial Transplant. 1998 May;13(5):1104-7. doi: 10.1093/ndt/13.5.1104. Nephrol Dial Transplant. 1998. PMID: 9623532 Review. No abstract available.
Complement activation and diabetic vascular complications.
Østergaard J, Hansen TK, Thiel S, Flyvbjerg A. Østergaard J, et al. Among authors: flyvbjerg a. Clin Chim Acta. 2005 Nov;361(1-2):10-9. doi: 10.1016/j.cccn.2005.04.028. Clin Chim Acta. 2005. PMID: 15996650 Review.
538 results